Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Flowscape is preparing a list change to Nasdaq

The Board of Directors of Flowscape Technology AB (“Flowscape”) today announces its intention to carry out a list change from Spotlight Stock Market to Nasdaq First North Growth Market. The process will be initiated immediatelyFlowscape is a leading PropTech company with a system for optimizing office space as well as increasing employee efficiency and well-being. Since 2016, Flowscape has been listed on the Swedish Spotlight Stock Market and in 2020 the company started its international expansion by opening sales offices in both the USA and the UK. Today, Flowscape has about 200 customers

Mandatory notification of trade

Oslo, 20 January 2022 Reference is made to the stock exchange announcements by Nordic Nanovector ASA ("Nordic Nanovector" or the "Company") on 19 December 2022 regarding a completed private placement (the "Private Placement") where the Company allocated 17,857,143 new shares (the "New Shares") at a subscription price of NOK 14 per share (the "Subscription Price"). In connection with the Private Placement, the following persons discharging managerial responsibilities (the "Primary Insiders") were allocated New Shares in the Private Placement at the Subscription Price: · Jan

BioStock: Promore Pharma prepares phase II study

With its drug candidates, Promore Pharma targets two comprehensive patient groups whose access to pharmaceutical products is limited – wound care and scarring. The main project ensereptide is being developed to inhibit scarring, with the aim of initiating a phase IIa study in early 2022. The company's second candidate, ropocamptide, for the stimulation of healing of chronic leg ulcers, is currently undergoing product development for an upcoming phase III study. BioStock talked to Promore Pharma's CEO Jonas Ekblom to learn more.Read the full interview with Promore Pharma's CEO Jonas Ekblom

New data from NeoDynamics PULSE study accepted for presentation at major US breast imaging conference

NeoDynamics AB (Spotlight Stock Market: NEOD), a medtech company dedicated to advancing diagnosis and care of breast cancer, will present results from the PULSE study illustrating the benefits of the novel biopsy device NeoNavia in challenging axillary lymph nodes, at the SBI/ACR Breast Imaging Symposium in Savannah, Georgia, taking place on May 16-19. The symposium is held to be the most important annual meeting for US breast imaging professionals. A subgroup analysis from the ethically approved German prospective multi-center study PULSE (ClinicalTrials.gov ID: NCT03975855), shows that

Immunovia appoints Philipp Mathieu as Acting CEO

LUND, SWEDEN –Immunovia AB (publ) announces that Philipp Mathieu has been appointed acting CEO and President with immediate effect. The search for a permanent CEO continues, as previously communicated. Philipp Mathieu has extensive experience as an adviser on corporate strategy, M&A and capital markets transactions to healthcare and life sciences companies, both in Europe and in the US. He has also held leadership positions in the financial sector and has extensive proficiency as an investor. The Board has entrusted him to rapidly advance the strategic priorities of the company, while it

Wärtsilä to supply 110 MW of flexible thermal balancing power to support Italy’s increasing focus on sustainable energy

Wärtsilä Corporation, Press release, 20 January 2022 at 09:30 AM EETThe technology group Wärtsilä will supply a natural gas fuelled 110 MW flexible power plant to Cassano d’Adda in Italy. Wärtsilä’s fast-starting internal combustion engine technology will be used to balance the power system and ensure its stability when the share of renewables is increased. The order was placed by A2A Gencogas, and it will be delivered on a full engineering, procurement, and construction (EPC) basis in partnership with Italian engineering group Cefla. The order is booked by Wärtsilä in January 2022. A2A

Sedana Medical appoints Johan Spetz as new CFO

Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announces the appointment of Johan Spetz as the company’s new Chief Financial Officer (CFO). Johan Spetz will take office no later than April 4, 2022, succeeding Susanne Andersson who will leave her position for another assignment.Johan Spetz joins Sedana Medical from investment bank Pareto Securities AB where he has been a partner for 8 years and headed up the Equity Research team in Stockholm for 6 years. Previously, Johan worked at Goldman Sachs in New York. “We are delighted to welcome Johan to Sedana Medical. His strong financial

Loomis AB to publish Full-year Report on February 3, 2022

Loomis AB will publish the Full-year Report 2021 on Thursday February 3, 2022,  at 8:00 a.m. (CET).   8.00 a.m. (CET) - Report release The report will be sent as a press release from Cision (www.cision.se) and will automatically be published on www.loomis.com when released.   8:30 a.m. (CET) - Presentation slides available For presentation slides, go to www.loomis.com and choose “Financial presentation”.   9.00 a.m. (CET) – Telephone conference and audio cast Analysts and media are invited to participate in a telephone conference where Loomis President & CEO

Exel Composites' Shareholders' Nomination Board's proposal to the Annual General Meeting

EXEL COMPOSITES PLC      STOCK EXCHANGE RELEASE      20 JANUARY 2022 at 09:30 EETExel Composites Plc’s Shareholders' Nomination Board presents the following proposals to the Annual General Meeting to be held on 25 March 2022: Number of members and composition of the Board of Directors The Nomination Board proposes that the number of members of the Board of Directors shall be confirmed to be six (previously five) and that Petri Helsky, Reima Kerttula, Helena Nordman-Knutson, Jouko Peussa and Kirsi Sormunen be re-elected as members of the Board of Directors for the term ending at the

Bioservo has received certification according to ISO 13485

Bioservo Technologies AB has received certification according to ISO13485 from Lloyd´s Register Quality Assurance Limited. The certification is part of a larger investment in medical technology products for people with impaired hand function and sales in a broader international market.During the year, the launch of Carbonhand 2.0 in Europe is planned, a completely new version of a force-strengthening glove that can be used both as an aid and as an aid in rehabilitation in the event of impaired hand function. ISO 13485 is an international standard that defines requirements for quality

Nordea appoints new Chief Risk Officer

Nordea Bank AbpStock exchange release – Changes board/management/auditors20 January 2022 at 09.30 EET Mark Kandborg, current Deputy Head of Nordea’s Large Corporates & Institutions business area, is appointed Chief Risk Officer and a member of the Group Leadership Team as of 1 April 2022. Nordea’s current Chief Risk Officer has decided to return to the United Kingdom after more than five years at Nordea and will be succeeded by Mark Kandborg, 50, who today is Deputy Head of Nordea’s Large Corporates & Institutions business area.  Mark Kandborg has worked at Nordea for 26 years

InCoax Networks AB publicize new financial targets

The Board and Directors of InCoax Networks AB (publ), today publicize new financial targets.The company is in an expansive phase with increased focus on providing licensing of software (Software as a service) and other services. Continued development of software features will broaden the use cases and increase the company’s addressable market. The ongoing activities are expected to add substantial potential for the Company. · For the current fiscal year, 2022, the target is to double net turnover compared to 2021. · For the fiscal year 2023, the aim is to continue grow net turnover

Divio Technologies AB (publ) has signed two Swedish IT-consultancy partnerships

Divio Technologies AB (publ) signed two new partnership deals with IT-consultancy firms in SwedenJon Levin, CEO of Divio: "In accordance with our new sales strategy, we signed two new partnership agreements with Swedish IT consulting companies. For Divio, the partnership means access to a broader customer base and for the IT consulting companies an improved cloud offering and state-of-the-art services to their customers. companies will use the platform for their own purposes and open up an impressive customer base.”

Arctic Paper Kostrzyn to reduce emissions by reusing energy

Arctic Paper Kostrzyn has signed a contract with NTP, a Polish-based company that will build a production facility on Arctic Paper's premises and start production in 2025. At the same time, Arctic Paper Kostrzyn will buy recycled residual heat from the new facility and use it to dry paper, which will reduce CO2 emissions by 20,000 tonnes annually.Arctic Paper Kostrzyn has a long experience with energy efficiency improvement and heat recovery solutions in cooperation with other companies. By recovering heat from the from new production process, Arctic Paper Kostrzyn will be supplied with 470,

Nightingale’s information security management certification continued with outstanding results in surveillance audit

Press release20 January 2022 at 9:15 a.m. (EET) A surveillance audit has been successfully completed for the ISO/IEC 27001:2013 certification Nightingale Health Plc (“Nightingale”) received a year ago in January 2021. ISO/IEC 27001:2013 is a globally recognized gold standard for information security management that defines the requirements of an information security management system. With its information security management system, Nightingale ensures that appropriate measures to secure data, products and services are maintained. The audit was performed by Inspecta Sertifiointi Oy,

Loyal Solutions annonuces half year results for 1/7-31/12 2021

Danish SaaS company Loyal Solutions, delivers on target in the first 6 months as a Nasdaq First North listed company, with 26% ARR growth and major milestones reached.CEO Peter Kisbye comments: “The period 1 July – 31 December 2021 (“the Period”) was the first half year post our IPO (“Initial Public Offering”) on Nasdaq First North Growth Market Stockholm, June 3 2021. As planned, we activated our recruitment plan post IPO, and all our new “non-IT” resources were operational from  October 3  2021. IT recruitment was, not unexpected, more time consuming. Based on the current recruiting

Better diagnosis of dizziness with a new technology

Patients with dizziness problems can now get better diagnosis in a simple and painless way. A new type of bone conduction speaker, easily attached behind the ear, can make the diagnosis more efficient and safer – especially for patients who also suffer from hearing problems. The technology has been developed by researchers at Chalmers University of Technology, Sweden, and is now ready for manufacturing. Hearing and balance are closely related. For patients with dizziness, this relationship is used for diagnosis. Commonly, a ‘VEMP’ test (Vestibular Evoked Myogenic Potentials)

Basware publishes Financial Statement Bulletin for January–December 2021 on Thursday, 3 February 2022

Basware Corporation, press release, 20 January 2022 at 9.00 a.m. EETBasware Corporation publishes Financial Statement Bulletin for 1 January–31 December 2021 on Thursday, 3 February 2022 at 8.45 a.m. EET. The report and presentation material will be available on the company’s investor website at investors.basware.com/en after publishing.Basware arranges a briefing for analysts and press, where CEO Klaus Andersen and CFO Martti Nurminen will comment on the events and financial performance of the past quarter and full year. The results briefing can be followed via live webcast or

Hansa Biopharma to host conference call to provide Year-End report for 2021 and Business Update

Lund, Sweden January 20, 2022 Hansa Biopharma AB (Nasdaq Stockholm: HNSA) will publish its Year-End report 2021 at 8:00 CET on February 3, 2022. All interested parties are invited to participate in a telephone conference, which will include a presentation of the Year-End results and a business update, on the same date at 14:00 CET/8:00am EST. The event will be hosted by Hansa Biopharma’s CEO, Søren Tulstrup, and CFO, Donato Spota, and the presentation will be held in English. Slides used in the presentation will be live on the company website during the call under “Events & Presentations”

Fiskars to publish its Financial Statement Release 2021 on February 4, 2022

Fiskars CorporationPress releaseJanuary 20, 2022 at 09:00 (EET) Fiskars to publish its Financial Statement Release 2021 on February 4, 2022Fiskars Corporation will publish the Financial Statement Release for 2021 on February 4, 2022 at approximately 8:30 a.m. (EET). The Financial Statement Release will be available on the company's website www.fiskarsgroup.com after publication. WebcastA webcast on the fourth quarter and full year results will be held on February 4, 2022 at 11:00 a.m. It will be held in English and can be followed at: https://fiskars.videosync.fi/q4-2021

Peab builds apartments and terraced houses in Bekkestua

Peab has been commissioned to build 30 apartments and eight terraced houses in Bekkestua. The customer is Hans Haslums vei Utvikling AS and the contract is worth NOK 150 million.Just north of Bekkestua center a rundown workshop hall is going to be replaced by 30 apartments and eight terraced houses with a gross area of 3,700 m2. The apartments will be two to four rooms of 44 to 149 m2. The terraced houses will have three floors and be around 155 m2. A parking garage will also be built, under the apartments. The homes will be built in an existing area with houses and outdoors share a yard

Nomination Committee Appointed in Respect of AGM 2022 in Alligator Bioscience AB

Lund, Sweden, January 20, 2021– Alligator Bioscience (Nasdaq Stockholm: ATORX) Alligator Bioscience (Nasdaq Stockholm: ATORX), announces today that the composition of the Nomination Committee prior to the Annual General Meeting on May 5, 2022 has changed as a result of a change of ownership. The composition of the Nomination Committee prior to the 2022 Annual General Meeting was announced in a press release on November 3, 2021. Allegro Investment, Inc. has since December 2021 acquired shares corresponding to approximately 22.2 percent of the total number of shares and votes in the

Konecranes’ financial statement release 2021 will be published on February 3, 2022

KONECRANES PLC PRESS RELEASE January 20, 2022 at 09:00 EET Konecranes’ financial statement release 2021 will be published on February 3, 2022 Konecranes will publish its financial statement release 2021 on Thursday, February 3, 2022 at approximately 8:30 a.m. EET. The report will be available on the company’s website at www.konecranes.com after publishing. A live international telephone conference for analysts, investors and media will be arranged on the publishing day at 10:30 a.m. EET. The event will be held in English. The financial statement release 2021 will be presented by

There are no items matching the current filter
There are no more items matching the current filter
Back to top